Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

S*BIO plans phase III program for pacritinib

Oct. 27, 2011

Solasia Pharma begins study of darinaparsin injection in Japan

Oct. 27, 2011

Immunovaccine clear to start phase I/II DPX-Survivac trial in Canada

Oct. 27, 2011

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

DelMar Pharmaceuticals commences phase I/II trial of VAL-083

Oct. 26, 2011

FDA grants IND clearance for phase II trial of Aeterna Zentaris' AEZS-108 in breast cancer

Oct. 26, 2011

Bayer's phase III CORRECT trial meets primary endpoint

Oct. 26, 2011

CDC advisory committee recommends Merck & Co.'s HPV vaccine for boys and young men

Oct. 26, 2011

California Stem Cell acquires stem cell therapy program for metastatic melanoma

Oct. 26, 2011

Novel omega-3 MUFAs show oncolytic potential

Oct. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...